Lucas W. Buchanan - Mar 2, 2022 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Mar 2, 2022
Transactions value $
-$55,340
Form type
4
Date filed
3/4/2022, 05:40 PM
Previous filing
Jan 14, 2022
Next filing
Aug 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +35.9K +19.41% $0.00 221K Mar 2, 2022 Direct F1
transaction SILK Common Stock Award $0 +29.4K +13.3% $0.00 250K Mar 2, 2022 Direct F1
transaction SILK Common Stock Tax liability -$55.3K -1.53K -0.61% $36.24 249K Mar 3, 2022 Direct F2
holding SILK Common Stock 13.5K Mar 2, 2022 Buchanan Grandchildren's Irrevocable Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Award $0 +32.7K $0.00 32.7K Mar 2, 2022 Common Stock 32.7K $37.07 Direct F4
transaction SILK Option (right to buy) Award $0 +26.8K $0.00 26.8K Mar 2, 2022 Common Stock 26.8K $37.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2023 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.
F3 These shares are held directly by the Buchanan Grandchildren's Irrevocable Trust, for which the Reporting Person serves as a co-trustee.
F4 One forty-eighth of the shares subject to the option shall vest on April 1, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.